Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous Atorvastatin in Hypercholesterolemia
NCT03611010Phase 2Completed
- Sponsor
- Cumberland Pharmaceuticals
- Start
- Aug 2018
- Primary completion
- Feb 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of atorvastatin in hypercholesterolemia, sponsored by Cumberland Pharmaceuticals. Started Aug 2018; status: completed.
02
Drugs
atorvastatin
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on NCT03611010.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03611010.